Lung Cancer Proteomics: Recent Advances in Biomarker Discovery

Lung cancer is the most common cause of cancer death in both men and women in Western countries, with a 5-year survival rate of 15%, which is among the lowest of all cancers. The high mortality from lung cancer is due not only to the late stage diagnosis but also to the lack of effective treatments...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Proteomics 2011-01, Vol.2011 (2011), p.198-204
Main Authors: Indovina, Paola, Marcelli, Eleonora, Maranta, Pasquale, Tarro, Giulio
Format: Article
Language:English
Subjects:
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3
cites cdi_FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3
container_end_page 204
container_issue 2011
container_start_page 198
container_title International Journal of Proteomics
container_volume 2011
creator Indovina, Paola
Marcelli, Eleonora
Maranta, Pasquale
Tarro, Giulio
description Lung cancer is the most common cause of cancer death in both men and women in Western countries, with a 5-year survival rate of 15%, which is among the lowest of all cancers. The high mortality from lung cancer is due not only to the late stage diagnosis but also to the lack of effective treatments even for patients diagnosed with stage I lung cancer. Therefore, there is an urgent need to identify new markers for early diagnosis and prognosis that could serve to open novel therapeutic avenues. Proteomics can represent an important tool for the identification of biomarkers and therapeutic targets for lung cancer since DNA-based biomarkers did not prove to have adequate sensitivity, specificity, and reproducibility. In this paper we will describe studies focused on the identification of new diagnostic, prognostic, and predictive markers for lung cancer, using proteomics technologies.
doi_str_mv 10.1155/2011/726869
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3196861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><airiti_id>P20151125004_201112_201710190011_201710190011_198_204</airiti_id><sourcerecordid>915038823</sourcerecordid><originalsourceid>FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3</originalsourceid><addsrcrecordid>eNqFkU1LJDEQhsOyoqKePO_StwVlNJWPTseDoOPXwsCKeA-ZTlqjMx1Npkf891bbOqwn61KV1MNblTeE7AI9AJDykFGAQ8XKqtQ_yCajmo4YKPFzVZflBtnJ-YFiCC0kF-tkg2FoqmGTHE-69q4Y27b2qbhOceHjPNT5qLjxtW8XxYlb9r1chLY4DXFu0yOCZyHXcenT6zZZa-ws-52PvEVuL85vx1ejyb_Lv-OTycgKUHpUal7rkikvaSVBeuqYU66RwjWeWVdNHQfqrMRqKpxSdUkln0qqLQdE-BY5HmSfuuncu36zZGfmKQVc6NVEG8zXThvuzV1cGg4arQEU-PMhkOJz5_PCzPEJfjazrY9dNhok5VXFOJL7A1mnmHPyzWoKUNNbbnrLzWA50r__X2zFfhqMwN4A3IfW2ZfwjdqvAfaI-MauYKG50gz7k6FvQwqLYB5il1q03VyjigRgEv_4XRFYnxRQ0LQf8OUAusILwd8AjESmTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>915038823</pqid></control><display><type>article</type><title>Lung Cancer Proteomics: Recent Advances in Biomarker Discovery</title><source>PubMed (Medline)</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Indovina, Paola ; Marcelli, Eleonora ; Maranta, Pasquale ; Tarro, Giulio</creator><contributor>Emmert-Buck, Michael R.</contributor><creatorcontrib>Indovina, Paola ; Marcelli, Eleonora ; Maranta, Pasquale ; Tarro, Giulio ; Emmert-Buck, Michael R.</creatorcontrib><description>Lung cancer is the most common cause of cancer death in both men and women in Western countries, with a 5-year survival rate of 15%, which is among the lowest of all cancers. The high mortality from lung cancer is due not only to the late stage diagnosis but also to the lack of effective treatments even for patients diagnosed with stage I lung cancer. Therefore, there is an urgent need to identify new markers for early diagnosis and prognosis that could serve to open novel therapeutic avenues. Proteomics can represent an important tool for the identification of biomarkers and therapeutic targets for lung cancer since DNA-based biomarkers did not prove to have adequate sensitivity, specificity, and reproducibility. In this paper we will describe studies focused on the identification of new diagnostic, prognostic, and predictive markers for lung cancer, using proteomics technologies.</description><identifier>ISSN: 2090-2166</identifier><identifier>EISSN: 2090-2174</identifier><identifier>DOI: 10.1155/2011/726869</identifier><identifier>PMID: 22229091</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Limiteds</publisher><subject>Review</subject><ispartof>International Journal of Proteomics, 2011-01, Vol.2011 (2011), p.198-204</ispartof><rights>Copyright © 2011 Paola Indovina et al.</rights><rights>Copyright © 2011 Paola Indovina et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3</citedby><cites>FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196861/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196861/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22229091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Emmert-Buck, Michael R.</contributor><creatorcontrib>Indovina, Paola</creatorcontrib><creatorcontrib>Marcelli, Eleonora</creatorcontrib><creatorcontrib>Maranta, Pasquale</creatorcontrib><creatorcontrib>Tarro, Giulio</creatorcontrib><title>Lung Cancer Proteomics: Recent Advances in Biomarker Discovery</title><title>International Journal of Proteomics</title><addtitle>Int J Proteomics</addtitle><description>Lung cancer is the most common cause of cancer death in both men and women in Western countries, with a 5-year survival rate of 15%, which is among the lowest of all cancers. The high mortality from lung cancer is due not only to the late stage diagnosis but also to the lack of effective treatments even for patients diagnosed with stage I lung cancer. Therefore, there is an urgent need to identify new markers for early diagnosis and prognosis that could serve to open novel therapeutic avenues. Proteomics can represent an important tool for the identification of biomarkers and therapeutic targets for lung cancer since DNA-based biomarkers did not prove to have adequate sensitivity, specificity, and reproducibility. In this paper we will describe studies focused on the identification of new diagnostic, prognostic, and predictive markers for lung cancer, using proteomics technologies.</description><subject>Review</subject><issn>2090-2166</issn><issn>2090-2174</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkU1LJDEQhsOyoqKePO_StwVlNJWPTseDoOPXwsCKeA-ZTlqjMx1Npkf891bbOqwn61KV1MNblTeE7AI9AJDykFGAQ8XKqtQ_yCajmo4YKPFzVZflBtnJ-YFiCC0kF-tkg2FoqmGTHE-69q4Y27b2qbhOceHjPNT5qLjxtW8XxYlb9r1chLY4DXFu0yOCZyHXcenT6zZZa-ws-52PvEVuL85vx1ejyb_Lv-OTycgKUHpUal7rkikvaSVBeuqYU66RwjWeWVdNHQfqrMRqKpxSdUkln0qqLQdE-BY5HmSfuuncu36zZGfmKQVc6NVEG8zXThvuzV1cGg4arQEU-PMhkOJz5_PCzPEJfjazrY9dNhok5VXFOJL7A1mnmHPyzWoKUNNbbnrLzWA50r__X2zFfhqMwN4A3IfW2ZfwjdqvAfaI-MauYKG50gz7k6FvQwqLYB5il1q03VyjigRgEv_4XRFYnxRQ0LQf8OUAusILwd8AjESmTw</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Indovina, Paola</creator><creator>Marcelli, Eleonora</creator><creator>Maranta, Pasquale</creator><creator>Tarro, Giulio</creator><general>Hindawi Limiteds</general><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><scope>188</scope><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Lung Cancer Proteomics: Recent Advances in Biomarker Discovery</title><author>Indovina, Paola ; Marcelli, Eleonora ; Maranta, Pasquale ; Tarro, Giulio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Indovina, Paola</creatorcontrib><creatorcontrib>Marcelli, Eleonora</creatorcontrib><creatorcontrib>Maranta, Pasquale</creatorcontrib><creatorcontrib>Tarro, Giulio</creatorcontrib><collection>Airiti Library</collection><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International Journal of Proteomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Indovina, Paola</au><au>Marcelli, Eleonora</au><au>Maranta, Pasquale</au><au>Tarro, Giulio</au><au>Emmert-Buck, Michael R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lung Cancer Proteomics: Recent Advances in Biomarker Discovery</atitle><jtitle>International Journal of Proteomics</jtitle><addtitle>Int J Proteomics</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>2011</volume><issue>2011</issue><spage>198</spage><epage>204</epage><pages>198-204</pages><issn>2090-2166</issn><eissn>2090-2174</eissn><abstract>Lung cancer is the most common cause of cancer death in both men and women in Western countries, with a 5-year survival rate of 15%, which is among the lowest of all cancers. The high mortality from lung cancer is due not only to the late stage diagnosis but also to the lack of effective treatments even for patients diagnosed with stage I lung cancer. Therefore, there is an urgent need to identify new markers for early diagnosis and prognosis that could serve to open novel therapeutic avenues. Proteomics can represent an important tool for the identification of biomarkers and therapeutic targets for lung cancer since DNA-based biomarkers did not prove to have adequate sensitivity, specificity, and reproducibility. In this paper we will describe studies focused on the identification of new diagnostic, prognostic, and predictive markers for lung cancer, using proteomics technologies.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Limiteds</pub><pmid>22229091</pmid><doi>10.1155/2011/726869</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-2166
ispartof International Journal of Proteomics, 2011-01, Vol.2011 (2011), p.198-204
issn 2090-2166
2090-2174
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3196861
source PubMed (Medline); Open Access: Wiley-Blackwell Open Access Journals
subjects Review
title Lung Cancer Proteomics: Recent Advances in Biomarker Discovery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A24%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lung%20Cancer%20Proteomics:%20Recent%20Advances%20in%20Biomarker%20Discovery&rft.jtitle=International%20Journal%20of%20Proteomics&rft.au=Indovina,%20Paola&rft.date=2011-01-01&rft.volume=2011&rft.issue=2011&rft.spage=198&rft.epage=204&rft.pages=198-204&rft.issn=2090-2166&rft.eissn=2090-2174&rft_id=info:doi/10.1155/2011/726869&rft_dat=%3Cproquest_pubme%3E915038823%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a4179-693c9627e508515e0d2d7df54dfe2ad8bd310da5d8bb4d77c6053b509a31dfe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=915038823&rft_id=info:pmid/22229091&rft_airiti_id=P20151125004_201112_201710190011_201710190011_198_204&rfr_iscdi=true